Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Complement System

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Inflammation

Inflammation

Inflammation: Introduction

Inflammation: Introduction

Inflammation is a fundamental, protective biological response of vascularized tissues to cellular injury, infection, or harmful stimuli. Its primary function is to eliminate the initial cause of injury, clear necrotic cells and damaged tissue, and initiate the necessary repair processes.Cardinal SignsAcute inflammation presents with classic signs. Redness results from vasodilation and increased blood flow. Heat is due to increased metabolism and circulation. Swelling results from the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease.

Ophthalmology science·2024

Same author

Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection.

PloS one·2024

Same author

Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration.

Current opinion in ophthalmology·2022

Same author

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.

Lancet (London, England)·2022

Same author

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Ophthalmology·2021

Same author

Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade.

Eye (London, England)·2020

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

Published on: June 17, 2020

The case for complement and inflammation in AMD: open questions.

Natalia Karagianni¹, Anthony P Adamis

¹Department of Opthalmology and Visual Sciences, University of Illinois at Chicago, Illinois, USA.

Advances in Experimental Medicine and Biology

|August 17, 2010

Summary

The complement cascade plays a key role in age-related macular degeneration (AMD) pathogenesis. Further research is needed to understand its role in vision-threatening AMD stages and guide therapeutic development.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Experiment Videos

Last Updated: Jun 10, 2026

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

Published on: June 17, 2020

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Area of Science:

Ophthalmology
Immunology
Genetics

Background:

The complement cascade is implicated in the pathogenesis of age-related macular degeneration (AMD).
Genetic data suggest complement activation in AMD is dysregulated and cannot be adequately inhibited.
Pharmacological targeting of the complement cascade is a potential therapeutic strategy for AMD.

Purpose of the Study:

To elucidate the precise role of the complement cascade in the pathogenesis of AMD.
To identify the specific complement components most suitable for therapeutic modulation.
To address remaining questions regarding complement's involvement in vision-threatening AMD stages like geographic atrophy and choroidal neovascularization.

Main Methods:

Review of genetic, preclinical, and immunolabeling data.
Analysis of the complement cascade's involvement in AMD.
Identification of therapeutic targets within the complement cascade.

Main Results:

Genetic data indicate complement cascade overactivation in AMD.
The exact role of complement in geographic atrophy and choroidal neovascularization remains to be determined.
Optimal complement targets for AMD therapy are yet to be identified.

Conclusions:

Understanding the complement cascade's role in AMD pathogenesis is crucial for developing effective treatments.
Further research is required to pinpoint specific complement targets for AMD therapy.
Clarifying complement's involvement in advanced AMD stages will guide future clinical therapeutics.